All posts by: Michael Zand

About Michael Zand

Putting A Number On CAR-T Deaths | Seeking Alpha – Seeking Alpha

Continue reading

2017-06-27 NEWS

Putting A Number On CAR-T Deaths | Seeking Alpha
Seeking Alpha
The toxicity of CAR-T therapies took on fresh importance with the discontinuation of Juno’s (NASDAQ:JUNO) Rocket study of JCAR015 owing to deaths from …

and more »

Continue reading

2017-06-27 NEWS

Proactive Investors UK

Widecells Groups claims landmark as stem cell insurance goes on sale in the UK
Proactive Investors UK
“We are leveraging Biovault’s register of over 25,000 samples to generate sales of our innovatively complete stem cell insurance product and are delighted that all new customers of the UK’s leading cord blood storage facility will become customers of …
WideCells Group Plc Cellplan is now live in the UKDirectorsTalk Interviews

all 2 news articles »

Continue reading

2017-06-27 NEWS

Proactive Investors UK

Widecells Groups claims landmark as stem cell insurance goes on sale in the UK
Proactive Investors UK
“We are leveraging Biovault’s register of over 25,000 samples to generate sales of our innovatively complete stem cell insurance product and are delighted that all new customers of the UK’s leading cord blood storage facility will become customers of …
WideCells Group Plc Cellplan is now live in the UKDirectorsTalk Interviews

all 2 news articles »

Continue reading

2017-06-27 NEWS

Genetic Engineering & Biotechnology News

Gene Therapy: A New Twist on an Old Helix
Genetic Engineering & Biotechnology News
The promise of fixing these genetic blunders of nature with one or a few treatments is close to becoming a reality. Since it was conceptualized in the 1970s, gene therapy has had its ups and downs. In 1990, it was first used to treat a patient. The